FKBP5增强子位点年龄依赖性DNA甲基化变化与精神分裂症皮质基因表达升高的关联
该研究分析两个独立队列死后人脑背外侧前额叶和眶额皮质样本(N=378例精神疾病患者,N=209例对照),探讨FKBP5基因DNA甲基化模式。研究发现多个CpG位点DNA甲基化与基因表达负相关,且与年龄、rs1360780基因型及精神疾病诊断相关。精神分裂症个体在近端增强子区域DNA甲基化水平显著降低,提示衰老与精神疾病诊断通过表观遗传机制影响FKBP5 mRNA表达。
要点
- FKBP5近端增强子区CpG位点DNA甲基化与基因表达负相关,两个队列均验证。
- 精神分裂症患者该区域DNA甲基化显著降低,尤其糖皮质激素反应元件相关CpG位点。
- DNA甲基化与年龄、rs1360780基因型及精神疾病诊断存在关联。
核心结论
- 衰老与精神疾病诊断与人额叶皮质FKBP5功能相关调控元件的DNA甲基化变化相关。
- FKBP5 mRNA水平的相关变化可能由这些表观遗传机制介导。
研究设计与样本
- 分析两个独立队列死后人脑背外侧前额叶和眶额皮质样本的DNA甲基化阵列、SNP基因分型、bulk RNA测序、单核RNA测序及snATAC测序数据。
- 样本包括N=378例重性精神疾病患者(精神分裂症、重性抑郁障碍或双相障碍)和N=209例对照。
主要发现
- FKBP5位点近端增强子区多个CpG位点DNA甲基化与基因表达负相关,两个队列均验证。
- 单核分析数据支持这些关联在所有主要细胞类型中的相关性。
- 该功能区域及其他位点观察到DNA甲基化与年龄、rs1360780基因型(CC vs CT/TT)及精神疾病诊断的关联。
- 精神分裂症个体近端增强子区域DNA甲基化水平显著降低,该区域显示年龄与基因型的汇聚效应,尤其见于糖皮质激素反应元件相关CpG位点。
关键数值与推荐
- 两个独立队列合计N=378例精神疾病患者和N=209例对照。
- rs1360780基因型比较为CC versus CT/TT。
临床怎么用
- FKBP5可作为精神疾病治疗靶点的证据进一步得到表观遗传机制支持。
- 精神分裂症患者FKBP5近端增强子区DNA甲基化降低,尤其糖皮质激素反应元件相关位点,提示应激相关通路参与。
局限性
- 研究为死后脑组织分析,无法确立因果关系。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: An increasingly compelling body of literature indicates that the glucocorticoid receptor cochaperone FK506-binding protein 51 (FKBP51; encoded by FKBP5) is a promising target for psychiatric therapeutics. Increased mRNA expression of FKBP5 in postmortem brains with psychiatric diagnoses and with aging have been reported previously. The epigenetic mechanisms underlying these effects in the human brain remain largely unknown. METHODS: The authors analyzed previously generated DNA methylation (DNAm) array, single-nucleotide polymorphism genotyping, and bulk RNA-, single-nucleus RNA-, and single-nucleus assay for transposase-accessible chromatin (snATAC)-sequencing data to examine FKBP5 DNAm patterns in postmortem human brain samples from the dorsolateral prefrontal cortex and orbitofrontal cortex of individuals who lived with a major psychiatric disorder (schizophrenia, major depressive disorder, or bipolar disorder) across two independent cohorts (N=378 cases and N=209 controls). RESULTS: Several cytosine-phosphate-guanine dinucleotides (CpGs) were identified across the proximal enhancer of the FKBP5 locus where DNAm was negatively correlated with gene expression, with validation across both cohorts. Data from single-nucleus analyses supported the relevance of these associations across all major cell types. In this functional region, as well as additional sites, associations were observed with age, rs1360780 genotype (CC versus CT/TT), and psychiatric diagnosis. Notably, individuals with schizophrenia exhibited significantly lower DNAm levels in the proximal enhancer region that showed additional converging effects of age and genotype, specifically in glucocorticoid response element-associated CpG sites. CONCLUSIONS: This evidence supports the association of aging and psychiatric diagnosis with changes in FKBP5 DNAm in functionally relevant regulatory elements of the human frontal cortex. This suggests that related changes in FKBP5 mRNA levels may be mediated by these epigenetic mechanisms.
引用
- Edmond KZ, Kaul D, Yusupov N, et al. Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia. Am J Psychiatry. 2026. PMID: 42642806. doi:10.1176/appi.ajp.20250473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。